Wouter Van Loocke

1.3k total citations
21 papers, 518 citations indexed

About

Wouter Van Loocke is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wouter Van Loocke has authored 21 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Wouter Van Loocke's work include Immune Cell Function and Interaction (6 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Wouter Van Loocke is often cited by papers focused on Immune Cell Function and Interaction (6 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Wouter Van Loocke collaborates with scholars based in Belgium, France and United States. Wouter Van Loocke's co-authors include Pieter Van Vlierberghe, Tom Taghon, Annelynn Wallaert, Frank Speleman, Kaat Durinck, Filip Matthijssens, Bruce Poppe, Bart Vandekerckhove, Georges Leclercq and Steven Goossens and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wouter Van Loocke

21 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wouter Van Loocke Belgium 14 309 153 149 103 97 21 518
Kaat Durinck Belgium 13 335 1.1× 178 1.2× 101 0.7× 98 1.0× 111 1.1× 26 548
Ingrid M. Ariës Netherlands 7 317 1.0× 112 0.7× 193 1.3× 85 0.8× 95 1.0× 9 494
Agnieszka A. Wendorff United States 6 446 1.4× 114 0.7× 100 0.7× 179 1.7× 139 1.4× 8 642
Julie A.I. Thoms Australia 15 428 1.4× 111 0.7× 97 0.7× 209 2.0× 108 1.1× 26 612
Barbara Szymanska Australia 6 306 1.0× 77 0.5× 75 0.5× 125 1.2× 155 1.6× 7 499
Junli Yan Singapore 12 536 1.7× 195 1.3× 193 1.3× 39 0.4× 40 0.4× 22 786
Luca Trentin Italy 15 381 1.2× 126 0.8× 39 0.3× 178 1.7× 154 1.6× 25 556
Linda Holmfeldt United States 8 393 1.3× 92 0.6× 106 0.7× 275 2.7× 281 2.9× 14 740
Zohar Sachs United States 12 246 0.8× 82 0.5× 73 0.5× 138 1.3× 23 0.2× 36 383
Takahiko Yasuda Japan 12 269 0.9× 101 0.7× 93 0.6× 131 1.3× 69 0.7× 33 465

Countries citing papers authored by Wouter Van Loocke

Since Specialization
Citations

This map shows the geographic impact of Wouter Van Loocke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Van Loocke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Van Loocke more than expected).

Fields of papers citing papers by Wouter Van Loocke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Van Loocke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Van Loocke. The network helps show where Wouter Van Loocke may publish in the future.

Co-authorship network of co-authors of Wouter Van Loocke

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Van Loocke. A scholar is included among the top collaborators of Wouter Van Loocke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Van Loocke. Wouter Van Loocke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Yujie, Celine Everaert, Wouter Van Loocke, et al.. (2023). Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma. iScience. 27(1). 108096–108096. 2 indexed citations
2.
Kiekens, Laura, Wouter Van Loocke, Filip Van Nieuwerburgh, et al.. (2022). IRF2 is required for development and functional maturation of human NK cells. Frontiers in Immunology. 13. 1038821–1038821. 8 indexed citations
3.
Matthijssens, Filip, Wouter Van Loocke, Sylvie Taveirne, et al.. (2022). The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency. eLife. 11. 18 indexed citations
4.
Kiekens, Laura, Sylvie Taveirne, Wouter Van Loocke, et al.. (2022). TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality. International Journal of Molecular Sciences. 23(19). 11345–11345. 2 indexed citations
5.
Zimmerman, Mark W., Nina Weichert‐Leahey, Belamy B. Cheung, et al.. (2021). MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers. 13(19). 4783–4783. 9 indexed citations
6.
Lammens, Tim, Ying Wu, Miriam Erlacher, et al.. (2021). Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia. Scientific Reports. 11(1). 2801–2801. 13 indexed citations
7.
Kiekens, Laura, Wouter Van Loocke, Sylvie Taveirne, et al.. (2021). T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells. Frontiers in Immunology. 12. 732511–732511. 30 indexed citations
8.
Mus, Liselot, Irina Lambertz, Candy Kumps, et al.. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific Reports. 10(1). 218–218. 19 indexed citations
9.
Taveirne, Sylvie, Wouter Van Loocke, Laura Kiekens, et al.. (2020). The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation. Blood. 136(3). 288–298. 47 indexed citations
10.
Loontiens, Siebe, Suzanne Vanhauwaert, Charlotte Gistelinck, et al.. (2019). Purification of high-quality RNA from a small number of fluorescence activated cell sorted zebrafish cells for RNA sequencing purposes. BMC Genomics. 20(1). 228–228. 7 indexed citations
11.
Wallaert, Annelynn, Wouter Van Loocke, Luis M. Hernández, et al.. (2017). Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing. Scientific Reports. 7(1). 7901–7901. 53 indexed citations
12.
Heetvelde, Mattias Van, Wouter Van Loocke, Wim Trypsteen, et al.. (2017). Evaluation of relative quantification of alternatively spliced transcripts using droplet digital PCR. SHILAP Revista de lepidopterología. 13. 40–48. 15 indexed citations
13.
Peirs, Sofie, Viktoras Frismantas, Filip Matthijssens, et al.. (2017). Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. Leukemia. 31(10). 2037–2047. 49 indexed citations
14.
Peirs, Sofie, Viktoras Frismantas, Filip Matthijssens, et al.. (2016). Targeting BET family proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. Haematologica. 101. 201–202. 1 indexed citations
15.
Walle, Inge Van de, Kaat Durinck, Katrien De Mulder, et al.. (2016). GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate. Nature Communications. 7(1). 11171–11171. 49 indexed citations
16.
Ghazavi, Farzaneh, Barbara De Moerloose, Wouter Van Loocke, et al.. (2016). Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Oncotarget. 7(45). 73769–73780. 27 indexed citations
17.
Ghazavi, Farzaneh, Barbara De Moerloose, Wouter Van Loocke, et al.. (2016). Unique Long Non-Coding RNA Expression Signature in ETV6/RUNX1-Driven B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 128(22). 3920–3920. 1 indexed citations
18.
Durinck, Kaat, Wouter Van Loocke, Joni Van der Meulen, et al.. (2015). Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia. Leukemia. 29(12). 2317–2327. 19 indexed citations
19.
Durinck, Kaat, Steven Goossens, Sofie Peirs, et al.. (2015). Novel biological insights in T-cell acute lymphoblastic leukemia. Experimental Hematology. 43(8). 625–639. 90 indexed citations
20.
Durinck, Kaat, Annelynn Wallaert, Inge Van de Walle, et al.. (2014). The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Haematologica. 99(12). 1808–1816. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaat Durinck Breakdown of academic impact, for papers by Ingrid M. Ariës Breakdown of academic impact, for papers by Agnieszka A. Wendorff Breakdown of academic impact, for papers by Julie A.I. Thoms Breakdown of academic impact, for papers by Barbara Szymanska Breakdown of academic impact, for papers by Junli Yan Breakdown of academic impact, for papers by Luca Trentin Breakdown of academic impact, for papers by Linda Holmfeldt Breakdown of academic impact, for papers by Zohar Sachs Breakdown of academic impact, for papers by Takahiko Yasuda
Rankless by CCL
2026